logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Diabetes Mellitus Noninsulindependent

    FiltersReset Filters
    14 results

    • brenzavvy

      (Bexagliflozin)
      TheracosBio, LLC
      Usage: BRENZAVVY is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes mellitus.

    • invokamet

      (canagliflozin and metformin hydrochloride)
      Janssen Pharmaceuticals, Inc.
      Usage: INVOKAMET and INVOKAMET XR are indicated as adjuncts to diet and exercise for improving glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes mellitus. Canagliflozin component reduces risks of major cardiovascular events and kidney disease in specific patient populations.

    • janumet

      (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)
      Merck Sharp & Dohme LLC
      Usage: JANUMET is indicated for improving glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.

    • janumet

      (sitagliptin and metformin hydrochloride)
      Merck Sharp & Dohme LLC
      Usage: JANUMET XR is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for use in patients with type 1 diabetes or those with a history of pancreatitis.

    • januvia

      (sitagliptin)
      Merck Sharp & Dohme LLC
      Usage: JANUVIA® is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.

    • jardiance

      (Empagliflozin)
      Boehringer Ingelheim Pharmaceuticals, Inc.
      Usage: JARDIANCE is indicated for reducing the risk of cardiovascular death and hospitalization in adults with heart failure, chronic kidney disease, and type 2 diabetes with established cardiovascular disease. It also aids glycemic control as an adjunct to diet and exercise in patients aged 10 and older with type 2 diabetes.

    • mounjaro

      (tirzepatide)
      Eli Lilly and Company
      Usage: MOUNJARO® is indicated as an adjunct to diet and exercise to enhance glycemic control in adults with type 2 diabetes mellitus. It is not studied in patients with pancreatitis and is not indicated for type 1 diabetes mellitus.

    • onglyza

      (SAXAGLIPTIN)
      AstraZeneca Pharmaceuticals LP
      Usage: ONGLYZA is indicated for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, both as monotherapy and in combination with other medications.

    • rybelsus

      (Oral Semaglutide)
      Novo Nordisk
      Usage: RYBELSUS is indicated for improving glycemic control in adults with type 2 diabetes mellitus, used alongside diet and exercise. It is not recommended for patients with type 1 diabetes mellitus.

    • segluromet

      (ertugliflozin and metformin hydrochloride)
      Merck Sharp & Dohme LLC
      Usage: SEGLUROMET® is indicated for improving glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise. It is not recommended for use in patients with type 1 diabetes.